Eagle Pharmaceuticals, Inc. Reports First Quarter 2017 Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Eagle Pharmaceuticals, Inc. Reports First Quarter 2017 Results

Eagle Pharmaceuticals (EGRX) Reports In-Line Q1 EPS

May 8, 2017 6:54 AM EDT

Eagle Pharmaceuticals (NASDAQ: EGRX) reported Q1 EPS of $1.42, in-line with the analyst estimate of $1.42. Revenue for the quarter came in at $76.8 million versus the consensus estimate of $70.37 million.

For earnings history and earnings-related data on Eagle Pharmaceuticals (EGRX) click here.

... More